US Stock MarketDetailed Quotes
DRUG Bright Minds Biosciences
- 1.1661
- -0.0139-1.18%
Trading Apr 19 13:46 ET
5.21MMarket Cap-906P/E (TTM)
1.1661High1.1400Low3.77KVolume1.1400Open1.1800Pre Close4.32KTurnover0.12%Turnover RatioLossP/E (Static)4.46MShares6.440052wk High1.19P/B3.71MFloat Cap1.090052wk Low--Dividend TTM3.18MShs Float44.7500Historical High--Div YieldTTM2.21%Amplitude1.0900Historical Low1.1480Avg Price1Lot Size
About Bright Minds Biosciences Company
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.
Company Profile
SymbolDRUG
Company NameBright Minds Biosciences
Listing DateNov 8, 2021
Founded2019
CEOMr. Ian McDonald
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address19 Vestry Street
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10013
Company Executives
- Name
- Position
- Salary
- Ian McDonald
- President, Chief Executive Officer and Director
- 626.18K
- Dr. Mark A. Smith
- Chief Medical Officer
- 450.92K
- Dr. Jan Pedersen, M.Sc.
- Director and Chief Science Officer
- 799.72K
- Ryan E. Cheung
- Chief Financial Officer
- 120.00K
- Nils Christian Bottler
- Independent Director
- 7.69K
- Jeremy Fryzuk
- Independent Director
- 7.69K
- Dr. David M. Weiner, M.D.
- Independent Director
- 22.04K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg